Industry News

New 1.85mm Right-Angle RF Adapters Intermateable with 2.4mm Connectors

IRVINE, Calif., April 24, 2024 /PRNewswire/ -- Pasternack, an Infinite Electronics brand and a leading provider of RF, microwave and millimeter wave products, has...

Aurora Humanitarian Initiative Co-Founder Noubar Afeyan Issues Global Call To Prevent A Second Armenian Genocide

CAMBRIDGE, Mass., April 24, 2024 /PRNewswire/ -- The Aurora Humanitarian Initiative today announced that co-founder Noubar Afeyan has issued a global call to action...

Health & Wellness Food Market Projected to Reach $859.43 billion by 2030 – Exclusive Report by 360iResearch

PUNE, India, April 23, 2024 /PRNewswire/ --The report titled "Health & Wellness Food Market by Type (Fresh & Natural, Functional Foods & Beverages, Heat...

Minister MacAulay announces appointment of new Chief Commissioner of the Canadian Grain Commission

OTTAWA, ON, April 23, 2024 /CNW/ - Today, the Honourable Lawrence MacAulay, Minister of Agriculture and Agri-Food, announced the appointment of David Hunt as Chief...

New Study in Colorado Reveals Alarming Rates of Colorado Teens Missing School

Study reveals majority of Colorado female teens have missed school due to lack of period products  Click here for photos DENVER, April 23, 2024 /PRNewswire/...

LG Energy Solution to Take Firm Stance Against Patent Infringers

A surge in patent infringement by latecomers in the battery industry, and subsequent market distortion caused by unlicensed use of patented technology, calls for...

Minister Petitpas Taylor to highlight housing measures in Budget 2024: Fairness for Every Generation

CHARLOTTETOWN, PE, April 23, 2024 /CNW/ - The Honourable Ginette Petitpas Taylor, Minister of Veterans Affairs and Associate Minister of National Defence, alongside Sean...

Monster Energy Snowboard Athletes Release Visually Stunning "Green Hour" Video

Monster Energy is proud to announce the worldwide premiere of the visually stunning "Green Hour" video, which explores snowboarding in Norway's backcountry amid the...

Novartis radioligand therapy Lutathera® FDA approved as first medicine specifically for pediatric patients with gastroenteropancreatic neuroendocrine tumors

Approval based on NETTER-P trial in which Lutathera demonstrated a consistent safety profile and comparable drug exposure between pediatric (ages 12-17) and adult patientsGastroenteropancreatic neuroendocrine...

Latest articles